Literature DB >> 13875925

Incidence and causes of secondary failure in treatment with tolbutamide. Experience with 2,500 patients treated up to five years.

R A CAMERINI-DAVALOS, A MARBLE.   

Abstract

Entities:  

Keywords:  TOLBUTAMIDE/therapy

Mesh：

Substances：

Year:  1962        PMID： 13875925     DOI： 10.1001/jama.1962.03050270003001

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  THE USE OF AZEPINAMIDE IN THE MANAGEMENT OF DIABETES MELLITUS.

Authors:  A WEINSTEIN; R MASSIE
Journal:  Trans Am Clin Climatol Assoc       Date:  1962

Review 2.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 3.  Oral hypoglycaemic agents. An update.

Authors:  A C Asmal; A Marble
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

4.  Case report: coeliac disease as a cause of secondary failure of glibenclamide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation.

Authors:  Dario Iafusco; Angela Zanfardino; Alessia Piscopo; Francesca Casaburo; Angelica De Nigris; Salvatore Alfiero; Giuseppina Russo; Mattia Arenella; Maria Cecilia Russo; Fabrizio Barbetti
Journal:  Diabetologia       Date:  2021-05-14       Impact factor: 10.122
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.